These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 138326

  • 1. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women.
    Frölich M, Lachinsky N, Moolenaar AJ.
    Acta Endocrinol (Copenh); 1977 Feb; 84(2):333-42. PubMed ID: 138326
    [Abstract] [Full Text] [Related]

  • 2. Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome.
    Falsetti L, Galbignani E.
    Contraception; 1990 Dec; 42(6):611-9. PubMed ID: 2150631
    [Abstract] [Full Text] [Related]

  • 3. Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone.
    Wild RA, Demers LM, Applebaum-Bowden D, Lenker R.
    Contraception; 1991 Aug; 44(2):113-24. PubMed ID: 1893706
    [Abstract] [Full Text] [Related]

  • 4. Androgen levels during cyproterone acetate and ethinyl oestradiol treatment of hirsutism.
    Rubens R.
    Clin Endocrinol (Oxf); 1984 Mar; 20(3):313-25. PubMed ID: 6233049
    [Abstract] [Full Text] [Related]

  • 5. Hair growth and androgen responses in hirsute women treated with continuous cyproterone acetate and cyclical ethinyl oestradiol.
    Jones DB, Ibraham I, Edwards CR.
    Acta Endocrinol (Copenh); 1987 Dec; 116(4):497-501. PubMed ID: 2962412
    [Abstract] [Full Text] [Related]

  • 6. Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives.
    Porcile A, Gallardo E.
    Fertil Steril; 1991 May; 55(5):877-81. PubMed ID: 1827074
    [Abstract] [Full Text] [Related]

  • 7. Impaired pregnenolone secretion after combined cyproterone acetate and ethynyl estradiol therapy in hirsute patients.
    Inaudi P, D'Ambrogio G, Massafra C, Facchini V, Genazzani AR.
    Gynecol Obstet Invest; 1982 May; 14(2):106-20. PubMed ID: 6288518
    [Abstract] [Full Text] [Related]

  • 8. Spironolactone as a single agent for long-term therapy of hirsute patients.
    Spritzer PM, Lisboa KO, Mattiello S, Lhullier F.
    Clin Endocrinol (Oxf); 2000 May; 52(5):587-94. PubMed ID: 10792338
    [Abstract] [Full Text] [Related]

  • 9. Cyproterone acetate and the treatment of hirsutism.
    Fraser IS, Shearman RP, Allen JK, McCarron G.
    Aust N Z J Obstet Gynaecol; 1983 May; 23(2):93-8. PubMed ID: 6226279
    [Abstract] [Full Text] [Related]

  • 10. Daily serum follicle-stimulating hormone, luteinizing hormone, and plasma testosterone and androstenedione in hirsute women with polycystic sclerotic ovaries: effects of diethylstilbestrol and norethindrone acetats.
    Daane TA, Dignam WJ, Frankland MV, Simmer HH, Parlow AF.
    Am J Obstet Gynecol; 1973 Oct 01; 117(3):392-9. PubMed ID: 4729733
    [Abstract] [Full Text] [Related]

  • 11. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
    Moutos D, Smith S, Zacur H.
    Contraception; 1995 Aug 01; 52(2):105-9. PubMed ID: 8536446
    [Abstract] [Full Text] [Related]

  • 12. An open study of Triphasil and Diane 50 in the treatment of acne.
    Wishart JM.
    Australas J Dermatol; 1991 Aug 01; 32(1):51-4. PubMed ID: 1834045
    [Abstract] [Full Text] [Related]

  • 13. Clinical and hormonal effects of the combination gonadotrophin-releasing hormone agonist plus oral contraceptive pills containing ethinyl-oestradiol (EE) and cyproterone acetate (CPA) versus the EE-CPA pill alone on polycystic ovarian disease-related hyperandrogenisms.
    Acién P, Mauri M, Gutierrez M.
    Hum Reprod; 1997 Mar 01; 12(3):423-9. PubMed ID: 9130733
    [Abstract] [Full Text] [Related]

  • 14. The effect of an oral contraceptive containing ethinylestradiol and desogestrel on hair growth and hormonal parameters of hirsute women.
    Ruutiainen K.
    Int J Gynaecol Obstet; 1986 Oct 01; 24(5):361-8. PubMed ID: 2880770
    [Abstract] [Full Text] [Related]

  • 15. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
    Karrer-Voegeli S, Rey F, Reymond MJ, Meuwly JY, Gaillard RC, Gomez F.
    Medicine (Baltimore); 2009 Jan 01; 88(1):32-45. PubMed ID: 19352298
    [Abstract] [Full Text] [Related]

  • 16. The effect of cyproterone acetate on pituitary-ovarian function and clinical symptoms in hirsute women.
    Lunell NO, Zador G, Carlström K, Eneroth P, Patek E, Wager J.
    Acta Endocrinol (Copenh); 1982 May 01; 100(1):91-7. PubMed ID: 6214134
    [Abstract] [Full Text] [Related]

  • 17. The effect of different contraceptive treatments on the serum concentration of dehydroepiandrosterone sulfate.
    Klove KL, Roy S, Lobo RA.
    Contraception; 1984 Apr 01; 29(4):319-24. PubMed ID: 6235099
    [Abstract] [Full Text] [Related]

  • 18. The influence of long-term treatment with cyproterone acetate or a cyproterone acetate-ethinyl oestradiol combination on androgen levels in blood of hirsute women.
    Frölich M, Vader HL, Walma ST, De Rooy HA.
    J Steroid Biochem; 1980 Jan 01; 12():499-501. PubMed ID: 6448324
    [No Abstract] [Full Text] [Related]

  • 19. Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.
    Barth JH, Cherry CA, Wojnarowska F, Dawber RP.
    Clin Endocrinol (Oxf); 1991 Jul 01; 35(1):5-10. PubMed ID: 1832346
    [Abstract] [Full Text] [Related]

  • 20. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
    Sobbrio GA, Granata A, D'Arrigo F, Arena D, Panacea A, Trimarchi F, Granese D, Pullè C.
    Acta Eur Fertil; 1990 Jul 01; 21(3):139-41. PubMed ID: 2149912
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.